Synthesis and initial PET imaging of new potential dopaimine D3 receptor radioligands (E)-4,3,2-[11C]methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides

被引:13
|
作者
Gao, MZ [1 ]
Mock, BH [1 ]
Hutchins, GD [1 ]
Zheng, QH [1 ]
机构
[1] Indiana Univ, Sch Med, Dept Radiol, Indianapolis, IN 46202 USA
关键词
(E)-4,3,2-[C-11]methoxy-N-(4-4-(2-methoxyphenyl)butyl-ci-nnamoylamides; radioligands; positron emission tomography; brain; D-3; receptors;
D O I
10.1016/j.bmc.2005.06.055
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
D-3 receptor radioligands (E)-4,3,2-[C-11]methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides (4-[C-11]MMC, [C-11]1a; 3-[C-11]MMC, [C-11]1b; and 2-[C-11]MMC, [C-11]1c) were synthesized for evaluation as novel potential positron emission tomography (PET) imaging agents for brain D-3 receptors. The new tracers 4,3,2-[C-11]MMCs were prepared by 0-[C-11]methylation of corresponding precursors (E)-4,3,2-hydroxy-N-4-(4-(2-methoxyphenyl)piperazin-l-yl)butyl-cinnamoylamides (4,3,2-HMCs) using [C-11]methyl triflate and isolated by the solid-phase extraction (SPE) purification procedure with 40-65% radiochemical ' Ids, decay corrected to end of bombardment (EOB), and a synthesis time of 15-20 min. The PET dynamic studies of the tracers [C-11]1a-c in rats were performed using an animal PET scanner, IndyPET-11, developed in our laboratory. The results show that the brain uptake sequence was 4-[C-11]MMC > 3-[C-11]MNIC > 2-[C-11]MMC, which is consistent with their in vitro biological properties. The initial PET blocking studies of the tracers 4,3,2-[C-11]MMCs with corresponding pretreatment drugs (E)-4,3,2-methoxy-N-4-(4-(2-methoxyphenyl)piperazin-1-yl)butyl-cinnamoylamides (4,3,2-MMCs, 1a-c) bad no effect on 4,3,2-[C-11]MMCs-PET rat brain imaging. These results suggest that the localization of 4,3,2-[C-11]MMCs in rat brain is mediated by nonspecific processes, and the visualization of 4,3,2-[C-11]MMCs-PET in rat brain is related to nonspecific binding. (c) 2005 Elsevier Ltd. All rights reserved.
引用
收藏
页码:6233 / 6243
页数:11
相关论文
共 50 条
  • [31] Design, Synthesis and 5-HT1A Binding Affinity of N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)tricyclo[3.3.1.13,7]decan-1-amine and N-(3-(4-(2-Methoxyphenyl)piperazin-1-yl)propyl)-3,5-dimethyl-tricylo[3.3.1.13,7]decan-1-amine
    Zoidis, Grigoris
    Isabel Loza, Maria
    Catto, Marco
    MOLBANK, 2022, 2022 (01)
  • [32] Novel heterocyclic trans olefin analogues of N-{4-[4-(2,3-dichlorophenyl)piperazin-1-yl]butyl}arylcarboxamides as selective probes with high affinity for the dopamine D3 receptor
    Grundt, P
    Carlson, EE
    Cao, JJ
    Bennett, CJ
    McElveen, E
    Taylor, M
    Luedtke, RR
    Newman, AH
    JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (03) : 839 - 848
  • [33] N-(4-[18F]-fluoropyridin-2-yl)-N-{2-[4-(2-methoxyphenyl)piperazin-1-yl]ethyl}carboxamides as analogs of WAY100635. New PET tracers of serotonin 5-HT1A receptors
    Garcia, Gonzalo
    Abet, Valentina
    Alajarin, Ramon
    Alvarez-Builla, Julio
    Delgado, Mercedes
    Garcia-Garcia, Luis
    Bascunana-Almarcha, Pablo
    Pena-Salcedo, Carmen
    Kelly, James
    Pozo, Miguel A.
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2014, 85 : 795 - 806
  • [34] Synthesis and evaluation of [O-methyl-11C]4-[3-[4-(2-methoxyphenyl)-piperazin-1-yl]propoxyl-4-aza-tricyclo[5.2.1.02,6]dec-8-ene-3,5-dione as a 5-HT1A receptor agonist PET ligand
    Majo, Vattoly J.
    Parsey, Ramin V.
    Prabhakaran, Jaya
    Mann, J. John
    Kumar, J. S. Dileep
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2008, 51 (3-4): : 132 - 136
  • [35] The Therapeutic Potential of 2-{[4-(2-methoxyphenyl) piperazin-1-yl]alkyl}-1H-benzo[d]imidazoles as Ligands for Alpha1-Adrenergic Receptor - Comparative In Silico and In Vitro Study
    Penjisevic, Jelena Z.
    Sukalovic, Vladimir B.
    Andric, Deana B.
    Surucic, Relja
    Kostic-Rajacic, Sladjana, V
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2022, 194 (08) : 3749 - 3764
  • [36] N-[2-[4-(4-chlorophenyl)piperazin-1-yl]ethyl]-3-methoxybenzamide:: A potent and selective dopamine D4 ligand
    Perrone, R
    Berardi, F
    Colabufo, NA
    Leopoldo, M
    Tortorella, V
    JOURNAL OF MEDICINAL CHEMISTRY, 1998, 41 (24) : 4903 - 4909
  • [37] SYNTHESIS OF A PET RADIOTRACER FOR STUDYING DOPAMINE D4 RECEPTORS: 3-(2-[11C]METHOXYPHENYL-PIPERAZIN-1-YLMETHYL)-7-AZAINDOLE ([11C]MPPMA)
    Suehiro, M.
    Simpson, N. R.
    Javitch, J. A.
    JOURNAL OF LABELLED COMPOUNDS & RADIOPHARMACEUTICALS, 2005, 48 : S194 - S194
  • [38] The Therapeutic Potential of 2-{[4-(2-methoxyphenyl)piperazin-1-yl]alkyl}-1H-benzo[d]imidazoles as Ligands for Alpha1-Adrenergic Receptor - Comparative In Silico and In Vitro Study
    Jelena Z. Penjišević
    Vladimir B. Šukalović
    Deana B. Andrić
    Relja Suručić
    Sladjana V. Kostić-Rajačić
    Applied Biochemistry and Biotechnology, 2022, 194 : 3749 - 3764
  • [39] Heterocyclic analogues of N-(4-(4-(2,3-Dichlorophenyl)piperazin-1-yl)butyl)arylcarboxamides with functionalized linking chains as novel dopamine D3 receptor ligands:: Potential substance abuse therapeutic agents
    Grundt, Peter
    Prevatt, Katherine M.
    Cao, Jianjing
    Taylor, Michelle
    Floresca, Christina Z.
    Choi, Ji-Kyung
    Jenkins, Bruce G.
    Luedtke, Robert R.
    Newman, Amy Hauck
    JOURNAL OF MEDICINAL CHEMISTRY, 2007, 50 (17) : 4135 - 4146
  • [40] Synthesis and in vitro evaluation of (S)-2-([11C]methoxy)4-[3-methyl-1-(2-piperidine-1-yl-phenyl)-butyl-carbamoyl]-benzoic acid ([11C]methoxy-repaglinide):: a potential β-cell imaging agent
    Wängler, B
    Beck, C
    Shiue, CY
    Schneider, S
    Schwanstecher, C
    Schwanstecher, M
    Feilen, PJ
    Alavi, A
    Rösch, F
    Schirrmacher, R
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2004, 14 (20) : 5205 - 5209